pargyline has been researched along with Developmental Coordination Disorder in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andringa, G | 1 |
| Eshuis, S | 1 |
| Perentes, E | 1 |
| Maguire, RP | 1 |
| Roth, D | 1 |
| Ibrahim, M | 1 |
| Leenders, KL | 1 |
| Cools, AR | 1 |
1 other study available for pargyline and Developmental Coordination Disorder
| Article | Year |
|---|---|
TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Macaca mulatta; Male; Motor Skills Disorders; MPTP | 2003 |